Successful outcome of DIC and life-threatening bleeding in a toddler with neuroblastoma treated with recombinant activated factor VII.

Suppr

超能文献

作者信息

Hatzipantelis Emmanouil S, Gombakis Nikolaos, Sidi Vasiliki, Papakonstantinou Evgenia, Koliouskas Dimitrios E

出版信息

Intern Emerg Med. 2008 Jun;3(2):171-3. doi: 10.1007/s11739-008-0104-8. Epub 2008 Feb 9.

DOI:10.1007/s11739-008-0104-8

PMID:18264677

Abstract

摘要

相似文献

Successful outcome of DIC and life-threatening bleeding in a toddler with neuroblastoma treated with recombinant activated factor VII.

Intern Emerg Med. 2008 Jun;3(2):171-3. doi: 10.1007/s11739-008-0104-8. Epub 2008 Feb 9.

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.单中心经验：重组凝血因子VIIa在无先天性出血性疾病儿童急性危及生命出血中的应用

Pediatr Hematol Oncol. 2008 Jun;25(4):301-11. doi: 10.1080/08880010802016904.

Angiographic documentation of the efficacy of recombinant activated factor VII (NovoSeven) to control diffuse bleeding in major trauma.重组活化因子VII（诺其）控制严重创伤中弥漫性出血疗效的血管造影记录。

Thromb Haemost. 2005 Dec;94(6):1327-8. doi: 10.1160/TH05-06-1327.

A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.重组凝血因子VIIa在获得性出血性疾病中的应用的批判性评估。

Br J Haematol. 2006 May;133(4):355-63. doi: 10.1111/j.1365-2141.2006.06023.x.

Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.重组活化凝血因子 VII 作为极低出生体重早产儿胃肠道出血和弥散性血管内凝血的止血剂。

J Pediatr Hematol Oncol. 2008 May;30(5):337-42. doi: 10.1097/MPH.0b013e3181639b28.

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII.

Br J Haematol. 2001 Jul;114(1):174-6. doi: 10.1046/j.1365-2141.2001.02878.x.

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.产后出血伴弥散性血管内凝血中的凝血因子VIIa

Obstet Gynecol. 2006 Sep;108(3 Pt 2):757-61. doi: 10.1097/01.AOG.0000197064.44340.d4.

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage.重组活化凝血因子 VII 成功治疗一例产科出血所致弥散性血管内凝血。

J Obstet Gynaecol Res. 2008 Aug;34(4 Pt 2):623-30. doi: 10.1111/j.1447-0756.2008.00896.x.

Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns.

Thromb Haemost. 2004 Jan;91(1):203-4.

Traumatic haemorrhage: a role for recombinant factor VIIa?创伤性出血：重组凝血因子VIIa能发挥作用吗？

Anaesthesia. 2009 Oct;64(10):1141-2. doi: 10.1111/j.1365-2044.2009.06086.x.

引用本文的文献

Effectiveness of recombinant activated factor VII in haemorragic cancer-related disseminated intravascular coagulation: a case report.重组活化因子VII在出血性癌症相关弥散性血管内凝血中的有效性：一例报告

Blood Transfus. 2011 Jul;9(3):336-8. doi: 10.2450/2010.0053-10. Epub 2010 Nov 26.

本文引用的文献

Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.重组活化凝血因子 VII（rFVIIa）用于控制出血的指南：以色列多学科 rFVIIa 工作组报告

J Thromb Haemost. 2005 Apr;3(4):640-8. doi: 10.1111/j.1538-7836.2005.01203.x.

Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation.

Blood Coagul Fibrinolysis. 2004 Oct;15(7):577-82. doi: 10.1097/00001721-200410000-00008.

The use of recombinant factor VIIa in the treatment of bleeding disorders.重组凝血因子VIIa在出血性疾病治疗中的应用。

Blood. 2004 Dec 15;104(13):3858-64. doi: 10.1182/blood-2004-06-2223. Epub 2004 Aug 24.

Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.

Blood Rev. 2003 Sep;17 Suppl 1:S11-21. doi: 10.1016/s0268-960x(03)90002-6.

A cell-based model of coagulation and the role of factor VIIa.基于细胞的凝血模型及凝血因子VIIa的作用。

Blood Rev. 2003 Sep;17 Suppl 1:S1-5. doi: 10.1016/s0268-960x(03)90000-2.

Blood transfusion, independent of shock severity, is associated with worse outcome in trauma.输血与创伤患者预后较差相关，且与休克严重程度无关。

J Trauma. 2003 May;54(5):898-905; discussion 905-7. doi: 10.1097/01.TA.0000060261.10597.5C.

Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.重组活化凝血因子VII对耻骨后前列腺切除术患者围手术期失血的影响：一项双盲安慰剂对照随机试验。

Lancet. 2003 Jan 18;361(9353):201-5. doi: 10.1016/S0140-6736(03)12268-4.

Recombinant factor VIIa (NovoSeven) as a hemostatic agent.重组凝血因子VIIa（诺其）作为一种止血剂。

Dis Mon. 2003 Jan;49(1):39-48. doi: 10.1053/shem.2001.29507b.

Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate.使用重组人凝血因子VIIa浓缩物逆转华法林引起的过度抗凝。

Ann Intern Med. 2002 Dec 3;137(11):884-8. doi: 10.7326/0003-4819-137-11-200212030-00009.

NovoSeven: mode of action and use in acquired haemophilia.

Intensive Care Med. 2002 Oct;28 Suppl 2:S222-7. doi: 10.1007/s00134-002-1469-1.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验